Solventum Corp | SOLV - Sales Revenues


Solventum Corp reported $2.1B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Abbott USD 11.46B 90M Dec/2025
Align Technology USD 1.05B 54.3M Dec/2025
Baxter International USD 2.97B 130M Dec/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Cencora USD 85.9B 5.2B Sep/2025
Dexcom USD 1.26B 50M Dec/2025
Insulet USD 783.8M 77.5M Dec/2025
Solventum Corp USD 2.1B 60M Sep/2025
West Pharmaceutical Services USD 805M 400K Dec/2025
Zimmer Biomet Holdings USD 2.24B 240M Dec/2025